North America Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity

North America oncology informatics market is expected to grow by 5.7% annually in the forecast period and reach $3,483.9 million by 2030 driven by the surge of cancer incidence, increasing cost of cancer treatment, and growing trend of reducing medical errors and readmission rates.
Highlighted with 28 tables and 43 figures, this 109-page report “North America Oncology Informatics Market 2020-2030 by Product Type (EHR, PHM, CDSS, DDDI), Cancer Type, Application (Medical, Surgical, Radiation), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America oncology informatics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America oncology informatics market in every aspect of the classification from perspectives of Product Type, Cancer Type, Application, End User, and Country.

Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Electronic Health Records (EHRs)
• Population Health Management (PHM)
• Clinical Decision Support System (CDSS)
• Drug Discovery and Development Informatics (DDDI)
• Data Analytics
• Image Analytics
• Other Product Types

Based on Cancer Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Colorectal Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Other Cancers

Based on Application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Medical Application
• Surgical Application
• Radiation Application

Based on End User, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Pharmaceutical Companies
• Life Science Companies
• Contract Research Organizations (CROs)
• Academic Institutes and Research Centers
• Other End Users

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Cancer Type, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in North America oncology informatics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Cerner Corporation
Change Healthcare
Elekta AB
F.Hoffmann-La Roche Ltd.
Hologic Inc.
IBM Corporation
Inspirata Inc.
Koninklijke Philips N.V.
Laboratory Corporation of America Holdings
McKesson Corporation
MIM Software, Inc.
Oncology Analytics, Inc
PerkinElmer, Inc.
RELX Group
Sirenas, LLC
UnitedHealth Group, Inc
Varian Medical Systems, Inc
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)